Little Rock law firm sues Pfizer over drugs.
Pfizer removed all marketing for Celebrex last week after questions were raised about the pain medication's safety. Emerson Poynter's lawsuit is the third Pfizer faces after disclosing that Celebrex and Bextra might increase the chances of heart problems in users.
Pfizer released a study that showed Celebrex users had double the chance of experiencing heart problems than patients taking a placebo.
Emerson Poynter filed the lawsuit on behalf of shareholders who purchased Pfizer stock between Nov. 1, 2000, and Dec. 16, 2004.
Emerson Poynter; whose Little Rock offices are at 2228 Cottondale Ave., was founded by partners John G. Emerson and Scott E. Poynter, both Arkansas natives. The firm specializes in securities purchaser class-action lawsuits.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Inside Business; Emerson Poynter LLP; Pfizer Inc.|
|Article Type:||Brief Article|
|Date:||Dec 27, 2004|
|Previous Article:||UAMS, Children's receive $8 million donation.|
|Next Article:||Feds lease land for oil, gas exploration.|
|Nurse sued when child dies from error in interpreting drug dosage.|